Proven to be safe and effective in clinical trials for the treatment of advanced fatty liver disease (NASH)

Aramchol is our first-in-class drug for the treatment of NASH that consists of two natural compounds

NASH is the most common liver disease, and growing at concerning rates, which affects 5-10% of adults

Demonstrated safety and efficacy in clinical trials for the treatment of NASH, an advanced stage of fatty liver disease

Aramchol, our investigational drug consisting of two natural compounds, is a first-in-class therapy for the treatment of NASH

NASH is the most common liver disease, and growing at concerning rates, which affects 5-10% of adults